Pliant Therapeutics's market cap is currently $183.17M. The company's EPS TTM is $-3.342; its P/E ratio is ―; Pliant Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.98. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.58M	$ 9.69M	$ 7.57M	$ 41.82M	$ 57.05M
Gross Profit	$ 1.58M	$ 6.00M	$ 4.37M	$ 41.82M	$ 57.05M
Operating Income	$ -184.15M	$ -127.20M	$ -19.99M	$ -41.65M	$ -1.23M
EBITDA	$ -158.23M	$ -118.85M	$ -95.73M	$ -40.34M	$ -118.00K
Net Income	$ -161.34M	$ -121.50M	$ -17.91M	$ -39.74M	$ 185.00K
Balance Sheet
Cash & Short-Term Investments	$ 494.25M	$ 331.19M	$ 200.60M	$ 276.89M	$ 102.77M
Total Assets	$ 512.15M	$ 350.61M	$ 221.22M	$ 295.53M	$ 119.06M
Total Debt	$ 11.37M	$ 15.81M	$ 7.19M	$ 283.00K	$ 444.00K
Net Debt	$ -51.86M	$ -17.87M	$ -44.47M	$ -50.60M	$ -85.36M
Total Liabilities	$ 38.58M	$ 37.27M	$ 22.16M	$ 12.46M	$ 119.50M
Stockholders' Equity	$ 473.58M	$ 313.34M	$ 199.06M	$ 283.06M	$ -435.00K
Cash Flow
Free Cash Flow	$ -117.28M	$ -96.39M	$ -77.40M	$ -38.80M	$ -3.71M
Operating Cash Flow	$ -116.36M	$ -94.63M	$ -75.44M	$ -37.27M	$ -2.75M
Investing Cash Flow	$ -127.01M	$ -150.20M	$ 73.70M	$ -210.87M	$ -17.93M
Financing Cash Flow	$ 274.40M	$ 226.85M	$ 2.53M	$ 213.21M	$ 45.54M

Currency in USD

Pliant Therapeutics Earnings and Revenue History

Income Statement >

Pliant Therapeutics Debt to Assets

Balance Sheet >

Pliant Therapeutics Cash Flow

Cash Flow >

Pliant Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing